Close Menu

One Lambda

The technology uses Thermo Fisher Scientific microarrays to measure transcript levels in order to diagnose rejection of solid organ transplants.

NEW YORK (GenomeWeb) – Diaxonhit today announced that its affiliate InGen has renewed an exclusive deal to distribute One Lambda's transplantation diagnostic tests in France.
Financial and other details of the partnership were not disclosed.

Title: System and method for nucleic acids sequencing by phased synthesis.
Patent Number: 8,747,751
Filed: June 10, 2009

NEW YORK (GenomeWeb News) – Regulators in the US and Canada have cleared One Lambda's companion software to molecular typing and antibody screening products, the Thermo Fisher Scientific business said late Wednesday.

NEW YORK (GenomeWeb News) – Genetic Technologies today announced it has executed a Covenant Not to Sue and Release agreement with transplant diagnostics firm One Lambda.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific has completed its acquisition of transplant diagnostics firm One Lambda for $925 million.

Cepheid last week filed suit against Roche seeking to invalidate a pair of PCR patents owned by Roche.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific has priced its $1.3 billion offering of senior notes, the firm announced after the close of the market yesterday.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that it intends to offer senior notes to cover the cost of its $925 million acquisition of One Lambda.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today announced it intends to buy transplant diagnostics firm One Lambda for $925 million in cash.

Pages

In PLOS this week: Mycobacterium abscessus linked to gastric conditions, placental gene expression changes associated with preterm birth, and more.

The Guardian reports that UK universities are looking into ways to reduce labs' reliance on single-use plastics.

People with certain gene variants tend to not like vegetables, particularly bitter ones, CNN reports.

MIT's Technology Review reports on a company's genetic test that gauges an embryo's susceptibility to certain diseases.